Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Dimeric Arylisoquinoline Alkaloids And Derivatives Thereof

  • Read more about Dimeric Arylisoquinoline Alkaloids And Derivatives Thereof
US Patent 6,331,630
Filed on 2000-03-16

Nitric Oxide-Releasing 1-[(2-Carboxylato)Pyrrolidin-1-YL]Diazen-1-IUM- 1,2-Diolates And Composition Comprising Same.

  • Read more about Nitric Oxide-Releasing 1-[(2-Carboxylato)Pyrrolidin-1-YL]Diazen-1-IUM- 1,2-Diolates And Composition Comprising Same.
US Patent 6,379,660
Filed on 2000-09-20

HUMAN CRIPTO-RELATED GENE

  • Read more about HUMAN CRIPTO-RELATED GENE
US Application 09/222,246
Filed on 1998-12-20

Novel Nitric oxide-releasing amidine and enamine-derived diazeniumdiol ates compositions and uses thereof and methods of making same.

  • Read more about Novel Nitric oxide-releasing amidine and enamine-derived diazeniumdiol ates compositions and uses thereof and methods of making same.
US Patent 6,232,336
Filed on 1999-12-22

Induction of Antigen-Specific Unresponsiveness by Glioblastoma Culture Supernatant(GCS)

  • Read more about Induction of Antigen-Specific Unresponsiveness by Glioblastoma Culture Supernatant(GCS)
Patent Cooperation Treaty
PCT/US00/07959
Filed on 2000-03-23

Combination Therapy With VIP Antagonist

  • Read more about Combination Therapy With VIP Antagonist
Patent Cooperation Treaty
PCT/US1999/024268
Filed on 1999-10-15

SYSTEM AND METHOD FOR SIMULATING A TWO-MULTIDIMENSIONAL RADIATION INTENSITY DISTRIBUTION OF PHOTON OR ELECTRON BEAMS

  • Read more about SYSTEM AND METHOD FOR SIMULATING A TWO-MULTIDIMENSIONAL RADIATION INTENSITY DISTRIBUTION OF PHOTON OR ELECTRON BEAMS
Patent Cooperation Treaty
PCT/US96/00481
Filed on 1996-01-05

Methods for Treating Tumors Using Antiangiogenic Compounds

  • Read more about Methods for Treating Tumors Using Antiangiogenic Compounds
Patent Cooperation Treaty
PCT/US00/12392
Filed on 2000-05-05

NEW TUMOR SUPPRESSOR GENE p33ING2

  • Read more about NEW TUMOR SUPPRESSOR GENE p33ING2
US Patent 6,790,948
Filed on 2000-02-25

Hydrazide Inhibitors of HIV-1 Integrase

  • Read more about Hydrazide Inhibitors of HIV-1 Integrase
Patent Cooperation Treaty
PCT/US2000/006361
Filed on 2000-03-10

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1506
  • Page 1507
  • Page 1508
  • Page 1509
  • Page 1510
  • Page 1511
  • Page 1512
  • Page 1513
  • Page 1514
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health